Bank of New York Mellon’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $206K | Buy |
16,522
+409
| +3% | +$5.11K | ﹤0.01% | 3950 |
|
2025
Q1 | $281K | Buy |
16,113
+1,325
| +9% | +$23.1K | ﹤0.01% | 3712 |
|
2024
Q4 | $563K | Buy |
14,788
+435
| +3% | +$16.6K | ﹤0.01% | 3438 |
|
2024
Q3 | $480K | Sell |
14,353
-4,795
| -25% | -$160K | ﹤0.01% | 3532 |
|
2024
Q2 | $649K | Buy |
+19,148
| New | +$649K | ﹤0.01% | 3426 |
|
2023
Q4 | – | Sell |
-319
| Closed | -$5.89K | – | 4341 |
|
2023
Q3 | $5.89K | Hold |
319
| – | – | ﹤0.01% | 4315 |
|
2023
Q2 | $5.51K | Hold |
319
| – | – | ﹤0.01% | 4356 |
|
2023
Q1 | $8.01K | Hold |
319
| – | – | ﹤0.01% | 4362 |
|
2022
Q4 | $61.3K | Hold |
319
| – | – | ﹤0.01% | 4205 |
|
2022
Q3 | $29K | Hold |
319
| – | – | ﹤0.01% | 4399 |
|
2022
Q2 | $24K | Sell |
319
-1,993
| -86% | -$150K | ﹤0.01% | 4476 |
|
2022
Q1 | $246K | Sell |
2,312
-27
| -1% | -$2.87K | ﹤0.01% | 4127 |
|
2021
Q4 | $600K | Sell |
2,339
-18
| -0.8% | -$4.62K | ﹤0.01% | 3681 |
|
2021
Q3 | $832K | Buy |
2,357
+168
| +8% | +$59.3K | ﹤0.01% | 3500 |
|
2021
Q2 | $1.09M | Buy |
2,189
+171
| +8% | +$85.1K | ﹤0.01% | 3354 |
|
2021
Q1 | $958K | Sell |
2,018
-57
| -3% | -$27.1K | ﹤0.01% | 3351 |
|
2020
Q4 | $3.66M | Buy |
2,075
+374
| +22% | +$659K | ﹤0.01% | 2509 |
|
2020
Q3 | $1.63M | Buy |
1,701
+39
| +2% | +$37.5K | ﹤0.01% | 2784 |
|
2020
Q2 | $1.93M | Buy |
1,662
+1,224
| +279% | +$1.42M | ﹤0.01% | 2708 |
|
2020
Q1 | $391K | Buy |
438
+224
| +105% | +$200K | ﹤0.01% | 3485 |
|
2019
Q4 | $187K | Buy |
+214
| New | +$187K | ﹤0.01% | 3926 |
|